India Malaria Vaccine Market, By Vaccine Type (Pre-Erythrocytic, Erythrocytic, Multi-antigen, Others), By Route of Administration (Intramuscular, Subcutaneous, Intradermal, Others), By Region, Competition, Forecast & Opportunities, 2028
Published Date: November - 2024 | Publisher: MIR | No of Pages: 320 | Industry: Healthcare | Format: Report available in PDF / Excel Format
View Details Buy Now 2890 Download Sample Ask for Discount Request CustomizationIndia Malaria Vaccine Market, By Vaccine Type (Pre-Erythrocytic, Erythrocytic, Multi-antigen, Others), By Route of Administration (Intramuscular, Subcutaneous, Intradermal, Others), By Region, Competition, Forecast & Opportunities, 2028
India malaria vaccine market is anticipated to observe impressive growth during the forecast period, 2024-2028. Rising awareness among people for early detection and treatments coupled with the rising number of people suffering from malaria are expected to augment the growth of the India malaria vaccine market.
Rise in Occurrences of Malaria
According to the World Health Organization (WHO), India accounted for 3% of the global malaria burden in 2019, with an estimated 247 million cases of malaria.
Download Free Sample ReportIncreasing Government Support
For instance, in 2022, the Ministry of Health and Family Welfare of India launched a campaign named Jan Abhiyaans with log bhaagidari (people’s participation) to enthuse and engage people and communities to ensure that their neighborhoods, premises, and homes for vector control and elimination.
Growing Awareness About the Importance of Malaria Treatment
Growing awareness among people about the importance of malaria treatment is a significant factor that can contribute to the growth of the India malaria vaccine market. In recent years, there has been growing awareness among people about the importance of malaria prevention, diagnosis, and treatment. This growing awareness has been supported by government initiatives and public health campaigns aimed at educating people about the disease and its prevention and treatment. As more people become aware of the importance of malaria prevention and treatment, there is a greater demand for effective tools for malaria control, including vaccines. Also, the growing awareness among people about the importance of malaria treatment and prevention is also creating a favorable environment for investment in malaria vaccine research and development. Investors and stakeholders are increasingly recognizing the potential of the malaria vaccine market, and the growing demand for malaria vaccines is likely to drive investment in this area. Furthermore, the growing awareness about the importance of malaria treatment is also creating a demand for affordable and effective malaria vaccines. This demand is particularly significant in India, where access to healthcare is often limited in rural and underprivileged areas. Affordable and effective malaria vaccines can help to reduce the burden of malaria in these areas and improve access to healthcare for vulnerable populations.
Growing Research & Development Activities
Recent Developments
In 2023, the India Health Fund (IHF), which is a funding initiative by Tata Trusts, has announced its support for the two platform tools developed by Ameliorate Biotech Pvt Ltd and Medprime Technologies, the tools are a fever panel to detect chikungunya, dengue, malaria and microscope-agnostic AI-enabled diagnosis software that is applicable across diseases.
In 2021, Serum Institute of India announced that it had partnered with the University of Oxford to develop a new mRNA-based malaria vaccine. The vaccine will use the same technology that was used to develop the Pfizer-BioNTech and Moderna COVID-19 vaccines. The mRNA vaccine has the potential to provide a more effective immune response compared to traditional vaccines.
For instance, in 2019, Abbott announced its collaboration between the government of the eastern Indian state of Odisha and Malaria No More to strengthen Odisha's malaria detection and surveillance system, and also to eliminate malaria in the state.
Such initiatives, product launches, mergers and acquisitions are expected to support the growth of the India malaria vaccine market in the forthcoming years.
Market Segmentation
India Malaria Vaccine Market is segmented into vaccine type, roue of administration and company. Based on vaccine type, India malaria vaccine market can be divided into pre-erythrocytic, erythrocytic, multi-antigen, and others. Based on route of administration, the India malaria vaccine market is divided into intramuscular, subcutaneous, intradermal, and others. Regionally, the India malaria vaccine market can be categorized into North India, South India, East India, and West India.
Market Players
Gennova Biopharmaceuticals Ltd, Zydus Group, Serum Institute of India Private Limited, Bharat Biotech International Limited, Indian Immunologicals Limited, Panacea Biotec, Mynvax, Cadila Pharmaceuticals, Biological E Limited, and Sanofi Pasteur
| Attribute | Details |
| Base Year | 2022 |
| Historic Data | 2018 – 2021 |
| Estimated Year | 2023 |
| Forecast Period | 2024 – 2028 |
| Quantitative Units | Revenue in USD Million, CAGR for 2018-2022 and 2023-2028 |
| Report coverage | Revenue forecast, Company share, Competitive landscape, Growth factors, and Trends |
| Segments covered | Vaccine Type Route of Administration Company |
| Country scope | North India, South India, East India, and West India. |
| Key companies profiled | Gennova Biopharmaceuticals Ltd, Zydus Group, Serum Institute of India Private Limited, Bharat Biotech International Limited, Indian Immunologicals Limited, Panacea Biotec, Mynvax, Cadila Pharmaceuticals, Biological E Limited, and Sanofi Pasteur |
| Customization scope | 10% free report customization with purchase. Addition or alteration to country, regional & segment scope. |
| Pricing and purchase options | Avail customized purchase options to meet your exact research needs. Explore purchase options |
| Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
FAQ'S
For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:
Within 24 to 48 hrs.
You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email
You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.
Discounts are available.
Hard Copy